Lotte Biologics CEO Richard Won-jik Lee announced the company’s full-fledged entry into the biopharma market as a CDMO at the 2023 JPMorgan Healthcare Conference.  (Source:Lotte Biologics)
Future Vision

Lotte Biologics Intends to Become a Global CDMO

Lotte Biologics has acquired the Syracuse plant in the United States from Bristol Myers Squibb Co. and now plans to expand it by adding ADC contract manufacturing services as well as clinical drug substance incubation and drug product facilities. The firm also plans to invest 3 billion dollars to develop three mega plants in Korea by 2030 with a total production capacity of 360,000 liters of antibody drugs.

Read on
Automatic extendable spray arm with self-adjusting movable spray nozzles allows efficient tablet coating for variable batch sizes from 10 to 100 %. (Source: Romaco)
Biggest Challenges in Coating

Is Coating as Efficient and Economical as It Could Be?

Coating is nowadays an integral part of pharmaceutical tablet and pellet production. Nevertheless, there are some problem areas that have not been adequately solved so far, some of which are nearly accepted, although they have an impact on almost every coating process and entail economic losses. To a certain extent, this is due to a presumed lack of possible solutions - but they do exist and are promising. In particular, a new generation of tablet coaters is addressing these challenges in an innovative way.

Read on
Plug Power and Nikola Corporation have announced a strategic relationship focused on moving the hydrogen economy forward. (Source: Pixabay)
Sustainability

Plug Power to Supply Green Hydrogen to Nikola

Plug Power has entered into a strategic relationship with Nikola Corporation to accelerate the hydrogen economy. Under this collaboration, Plug Power will supply green hydrogen to Nikola from January 1, 2023 and Nikola will also purchase a 30 TPD liquefaction system from Plug for its Arizona Hydrogen Hub.

Read on